In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
James E. Dahlman(Georgia Institute of Technology), Daniel G. Anderson(Massachusetts Institute of Technology), Omar F. Khan(University of Toronto), Danielle Seedorf(Massachusetts Institute of Technology), Dayna K. Mudge(Harvard University), Tatiana I. Novobrantseva(Alnylam Pharmaceuticals (United States)), Lauren Speciner(Alnylam Pharmaceuticals (United States)), Aude Thiriot(Harvard University), Yizhou Dong(Allen Institute for Brain Science), Apeksha Dave(Children's Hospital of Philadelphia), Matthew J. Webber(Boston Children's Hospital), Vera M. Ruda(Boston Biomedical Research Institute), Roman L. Bogorad(Massachusetts Institute of Technology), Ludmila Abezgauz(Technion – Israel Institute of Technology), Tim Racie(Alnylam Pharmaceuticals (United States)), Ulrich H. von Andrian(Harvard University), Róbert Langer(Massachusetts Institute of Technology), Kamaljeet Singh Sandhu(Massachusetts Institute of Technology), Abigail K. R. Lytton‐Jean(Massachusetts Institute of Technology), Brian T. Kalish(Boston Children's Hospital), Rubin M. Tuder(University of Colorado Denver), Mark W. Kieran(Children Cancer Hospital), Gaurav Sahay(Oregon Health & Science University), Shan Jiang(Harvard–MIT Division of Health Sciences and Technology), Yiping Xing(Massachusetts Institute of Technology), Akin Akinc(Alnylam Pharmaceuticals (United States)), Matthias Nahrendorf(Massachusetts General Hospital), Dganit Danino(Technion – Israel Institute of Technology), Christopher G. Levins(Harvard–MIT Division of Health Sciences and Technology), Hao Yin(Wuhan University), Lynelle P. Smith, Mario Pérez, Dipak Panigrahy(Beth Israel Deaconess Medical Center), Partha Dutta(Harvard University), Victor Koteliansky(Centre National de la Recherche Scientifique), Siddharth Jhunjunwala(Massachusetts Institute of Technology), Taylor E. Shaw(Massachusetts Institute of Technology), Andrew Bader(Harvard–MIT Division of Health Sciences and Technology), Kevin Fitzgerald(Epsilon Systems (United States)), Carmen Barnes(Alnylam Pharmaceuticals (United States)), Avi Schroeder(Technion – Israel Institute of Technology), Klaus Charissé(Alnylam Pharmaceuticals (United States)), Hendrik B. Sager(German Centre for Cardiovascular Research)
Cited by 580
Related Papers
Lipid nanoparticles for mRNA delivery
|Nature Reviews Materials|2021|3.5k
Transdermal drug delivery
|Nature Biotechnology|2008|3.4k
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
|Advanced Drug Delivery Reviews|2016|3.2k
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k